-
Mashup Score: 145Palmitoylated Sept8-204 modulates learning and anxiety by regulating filopodia arborization and actin dynamics - 4 month(s) ago
The lipid modification S-palmitoylation enables a neuronal variant of Sept8 to facilitate cognition.
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 19Targeted radiation therapy: Y-90 and liver cancer - Mayo Clinic Comprehensive Cancer Center Blog - 4 month(s) ago
Dr. Jeremy McBride explains Y-90, a type of targeted radiation therapy that may be an option for people with liver […]
Source: cancerblog.mayoclinic.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 144Palmitoylated Sept8-204 modulates learning and anxiety by regulating filopodia arborization and actin dynamics - 4 month(s) ago
The lipid modification S-palmitoylation enables a neuronal variant of Sept8 to facilitate cognition.
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet-
Researchers at @KECKSchool_USC found a direct link between circadian clock proteins and #livercancer. CLOCK and BMAL1 proteins were identified as crucial for liver cancer cell replication, and inhibiting them led to interrupted replication and cell death. https://t.co/piCxzbG78G https://t.co/8ahWpFukWV
-
-
Mashup Score: 141Palmitoylated Sept8-204 modulates learning and anxiety by regulating filopodia arborization and actin dynamics - 4 month(s) ago
The lipid modification S-palmitoylation enables a neuronal variant of Sept8 to facilitate cognition.
Source: www.science.orgCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1Fewer Than 1 in 4 Patients With HCV-Related HCC Get DAAs - 5 month(s) ago
Early uncertainty about the safety of noninterferon antivirals in patients with liver cancer may have contributed to the slow acceptance of direct-acting antiviral agents in this population.
Source: www.medscape.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Dr. Christopher Lieu on the Next Frontier of Liver Cancer Therapy - 7 month(s) ago
Dr. Christopher Lieu, of the University of Colorado Cancer Center, spoke with GI Oncology Now about the upcoming liver cancer trials he has his eye on. He noted that a lot of research around treating metastatic liver cancer is now focused on immunotherapies, with the ultimate goal of having the therapies train the immune system to find, detect, and kill the cancer. Dr. Lieu also discussed the data from ESMO 2023 that he is most interested in seeing. Watch now to gain valuable liver cancer insights, and
Source: docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 13stats - 7 month(s) ago
Hepatitis A, Hepatitis B, and Hepatitis C are all viruses that affect the liver, though they are distinctly unique.
Source: www.cdc.govCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Hepatitis and Liver Cancer Statistics | Did You Know? - 7 month(s) ago
This video features the link between Hepatitis virus infection and liver cancer. Risk factors for liver cancer include heavy alcohol use, diabetes, obesity, …
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0#OctoberIs4Livers campaign aims to ‘turn the tide’ during Liver Cancer Awareness Month - 7 month(s) ago
Liver Cancer Awareness Month, celebrated every October, seeks to raise awareness about the third deadliest cancer in the United States, with approximately 41,000 new cases and as many as 30,000 deaths each year.To educate physicians on liver cancer management and prevention while empowering patients impacted by liver cancer, the Global Liver Institute has launched a social media campaign with the
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
Scientists have discovered a self-sustaining mechanism that may drive the spread of hepatocellular carcinoma—and demonstrate that this molecular loop could offer a target for new therapies for this aggressive and deadly #LiverCancer. @SciSignal https://t.co/nkSZ9Jl0oy https://t.co/bJGZPKNYp6